CClinicalTrials.gg
RecruitingNCT05873088Updated May 24, 2023

Effects of Isometric Versus Isotonic Exercise in Female Patients With Osteoarthritis

An interventional study of Isometric and Isotonic Exercise in Osteoarthritis, sponsored by Superior University. Recruiting at 1 site in Pakistan. Open to female participants aged 35 Years to 60 Years. Per ClinicalTrials.gov, last updated 2023-05-24.

Sponsored by Superior University · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Primary completion was expected by Jun 2023, 3 years 4 months ago, but the record still lists the study as recruiting.
  • Started Apr 2023; still recruiting 3 years 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
35 Years to 60 Years
Sex
Female
01

Study summary

to find out the Effects of Isometric Versus Isotonic Exercise in Female Patients With Osteoarthritis

02

Conditions studied

  • Osteoarthritis

Browse trials for

03

In context

Osteoarthritis

4,398 studies on the registry are indexed under Osteoarthritis; 582 are open to participants now.

This study's planned enrollment of 64 is close to the median of 70 across 3,440 interventional studies indexed under Osteoarthritis.

Browse Osteoarthritis studies →

Lead sponsor

Superior University is the lead sponsor of 242 studies on the registry; 24 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
35 Years to 60 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Female patients with osteoarthritis Age group of 35 to 60

Exclusion criteria

Exclusion Criteria:

  • Patients admitted in ICU or HDU Patients with any mental illness
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
64 participants (estimated)

Study arms

  • Other
    Isometric

    Diagnostic Test: Isometric

  • Experimental
    Isotonic Exercise

    Diagnostic Test: Isotonic Exercise

Interventions

  • Diagnostic testIsometric

    Effects of Isometric Exercise in Female Patients With Osteoarthritis

  • Diagnostic testIsotonic Exercise

    Effects of Isotonic Exercise in Female Patients With Osteoarthritis

06

What researchers measure

Primary outcomes

  1. WOMAC Scale

    Isometric Versus Isotonic Exercise in Female Patients With Osteoarthritis by using WOMAC Scale

    Time frame: 6 Months

  2. VAS score

    Isometric Versus Isotonic Exercise in Female Patients With Osteoarthritis by using VAS score

    Time frame: 6 Months

07

Study locations

1 of 1 sites recruiting
  • Chaudhary Muhammad Akram Hospital
    Lahore, Punjab, Pakistan
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 24, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05873088
Lead sponsor
Superior University
Responsible party
Muhammad Naveed Babur (Principal Investigator, Superior University) — Principal investigator
First posted
May 24, 2023
Start date
Apr 1, 2023
Primary completion
Jun 1, 2023 (estimated)
Completion
Aug 31, 2023 (estimated)
Last update
May 24, 2023

Study contacts

Abdullah, DPT
Contact
dptm-f18-029@superior.edu.pk
+923427159206

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion